共 50 条
- [21] The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's disease JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (05): : 589 - 594
- [27] EFFECT OF ENTACAPONE, A PERIPHERALLY ACTING CATECHOL-O-METHYLTRANSFERASE INHIBITOR, ON THE MOTOR RESPONSE TO ACUTE TREATMENT WITH LEVODOPA IN PATIENTS WITH PARKINSONS-DISEASE JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (02): : 186 - 189
- [29] Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol-O-Methyltransferase Activity and Motor Response in Patients With Parkinson Disease CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (03): : 232 - 240